These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19734590)

  • 1. [Expression and significance of matrix metalloproteinase-1,9, tissue inhibitor of metalloproteinase-4 and extracellular matrix metalloproteinase inducer in the myocardium of congestive heart failure in patients with rheumatic heart diseases].
    Zhao Y; Zhou X; Liao X; Yang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):790-5. PubMed ID: 19734590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
    Wang W; Zhang HT; Yang XL
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
    Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G
    J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence and role of expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 9 in aseptic loosening of prosthesis].
    Qi Q; Dai M; Dong X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Oct; 27(10):1175-80. PubMed ID: 24397126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction.
    Nie R; Xie S; Du B; Liu X; Deng B; Wang J
    Arch Med Res; 2009 Oct; 40(7):605-11. PubMed ID: 20082877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance of matrix metalloproteinases/tissue inhibitor of metalloproteinase-1 and loss of fibronectin expression in patients with congestive heart failure.
    Yang DC; Ma ST; Tan Y; Chen YH; Li D; Tang B; Chen JS; Su XH; Li G; Zhang X; Yang YJ
    Cardiology; 2010; 116(2):133-41. PubMed ID: 20606426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
    Yoon YW; Kwon HM; Hwang KC; Choi EY; Hong BK; Kim D; Kim HS; Cho SH; Song KS; Sangiorgi G
    Atherosclerosis; 2005 May; 180(1):37-44. PubMed ID: 15823273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial matrix metalloproteinase-3 and matrix metalloproteinase inhibitor-1 expression in congestive heart failure.
    Wang X; Yang L; Qi F; Et Al
    Zhonghua Nei Ke Za Zhi; 2002 Jul; 41(7):453-5. PubMed ID: 12189113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2), and EMMPRIN (CD147) in multiple myeloma.
    Urbaniak-Kujda D; Kapelko-Slowik K; Prajs I; Dybko J; Wolowiec D; Biernat M; Slowik M; Kuliczkowski K
    Hematology; 2016 Jan; 21(1):26-33. PubMed ID: 26268417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
    Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
    J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
    Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.
    Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V
    J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance and Expressions of MMP-1, TIMP-1 and TGF-β1 in Valve Tissue of Rheumatic Heart Disease].
    Yu Y; Li ZQ; Chen K; Zhan P; Liao J; Ruan QY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):52-56. PubMed ID: 28612558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and extracellular metalloproteinase inducer by interleukin-17 in human periodontal ligament fibroblasts.
    Wu Y; Zhu L; Wei H; Peng B
    J Endod; 2013 Jan; 39(1):62-7. PubMed ID: 23228259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR
    Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer.
    Morikawa A; Ohara N; Xu Q; Nakabayashi K; DeManno DA; Chwalisz K; Yoshida S; Maruo T
    Hum Reprod; 2008 Apr; 23(4):944-51. PubMed ID: 18281245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation].
    Wang W; Wu PS; Yang XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1160-2. PubMed ID: 20501421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
    Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.